Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule - Hombach, A; Wieczarkowiecz, A; Marquardt, T (J Immunol, 2001)
et al.